LysoPI, 16:0 LPI
Produktgrößen
100 ug
£228,00
ECH-P-0160-100UG
500 ug
£622,00
ECH-P-0160-500UG
1 mg
£1073,00
ECH-P-0160-1MG
Über dieses Produkt
- SKU:
- ECH-P-0160
- Weitere Details:
- 1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (LysoPI, 16:0 LPI) is a synthetic, purified palmitoyl PI. \n \nLysophospholipids are lipid mediators which elicit a diverse array of cellular responses through activation of phospholipid specific G protein-coupled receptors. Lysophosphatidylinositol (LPI) induces a number of cellular effects through binding to the GPR55 receptor including angiogenesis, bone morphogenesis, cancer progression and pain. In addition LPI is thought to be a biomarker for certain cancers. \n \n \n \nStorage \n-20 °C or below \nReferences \n1) K. Makide, et al "Novel lysophosphoplipid receptors: their structure and function" Journal of Lipid Research, 2014, 55, 1986. \n2) J.M. Moreno-Navarette, et al. "The l-a-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity" Diabetes, 2012, 61, 281-291. \n3) M. Falasca & R. Ferro. "Role of the lysophosphatidylinositol/GPR55 axis in cancer" Advances in Biological Regulation, 2016, 60, 88-93. \n \n \n \nDocuments \nTechnical Data Sheet, Echelon
- Versandbedingungen:
- Dry Ice
- Lagerbedingungen:
- Please refer to datasheet
- Hersteller:
- Echelon Biosciences
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
